This early-stage study is testing whether injecting an experimental therapy called RP1 directly into skin cancer tumors can help shrink them before surgical removal. The trial will enroll up to 12 adults with resectable cutaneous squamous cell carcinoma to assess safety and see i…
Phase: PHASE1, PHASE2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC